Participants
anaemia, parasitemia, malaria
ANAEMIA, PARASITEMIA, MALARIA
Participants were eligible for the trial if they had a capillary haemoglobin concentration below 10·0 g/dL (moderate or severe anaemia) measured by HemoCue 301+ (HemoCue AB, Angelholm, Sweden), were Women were screened for anaemia and parasitemia at antenatal clinics in health centres in Blantyre and Zomba; participants were usually screened during their first antenatal visit. If women met anaemia criteria but had a positive RDT, they were treated for malaria as per national guidelines (usually with artemether-lumefantrine)